Joel Greenblatt - Gotham Asset Management
Holding/activity history for Theravance Biopharma, Inc. (TBPH)
← All TBPH superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 45,212 | <0.01 | Add 99.35% | <0.01 | $13.08–21.03 · VW $17.48i | $733,791 | SEC |
| 2025 Q4 | 22,680 | <0.01 | Buy | <0.01 | $13.50–20.33 · VW $17.60i | $424,343 | SEC |
| 2017 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | $27.80–37.18 · VW $32.23i | SEC | |
| 2016 Q4 | 9,571 | <0.01 | Buy | <0.01 | $24.54–38.92 · VW $29.81i | $305,000 | SEC |
| 2016 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | $12.87–19.00 · VW $16.34i | SEC | |
| 2015 Q4 | 69,582 | <0.01 | Buy | <0.01 | $10.56–19.75 · VW $16.28i | $733,000 | SEC |
Price snapshot:
Current price$16.90
Avg. buy price$17.47
+/- since buy-3.29%
52-week low$10.82
52-week high$21.03